Editorials Direct to consumer advertising of drugs in Europe BMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39310.506308.AD (Published 13 September 2007) Cite this as: BMJ 2007;335:526 Article Related content Metrics Responses Peer review Related articles Editor's Choice Tooth and nail Published: 04 October 2007; BMJ 335 doi:10.1136/bmj.39357.591076.47 Education And Debate Grading quality of evidence and strength of recommendations Published: 17 June 2004; BMJ 328 doi:10.1136/bmj.328.7454.1490 Letter The world of the market place Published: 04 October 2007; BMJ 335 doi:10.1136/bmj.39346.496690.3A Feature What have we learnt from Vioxx? Published: 18 January 2007; BMJ 334 doi:10.1136/bmj.39024.487720.68 See more Cancer drugs remain FDA approved despite lack of benefit, study finds BMJ December 06, 2016, 355 i6568; DOI: https://doi.org/10.1136/bmj.i6568 Johnson & Johnson is ordered to pay $1bn over faulty hip implants BMJ December 06, 2016, 355 i6551; DOI: https://doi.org/10.1136/bmj.i6551 Bill to boost medical research funding and speed drug approval passes US house BMJ December 01, 2016, 355 i6498; DOI: https://doi.org/10.1136/bmj.i6498 Trial of novel leukaemia drug is stopped for second time after two more deaths BMJ November 25, 2016, 355 i6376; DOI: https://doi.org/10.1136/bmj.i6376 Promise of new Alzheimer’s drug is dashed after lack of evidence BMJ November 24, 2016, 355 i6362; DOI: https://doi.org/10.1136/bmj.i6362 Cited by... Multinational comparison of new antidepressant use in older adults: a cohort studyAbstract Fulltext PDF 'At-risk individuals responses to direct to consumer advertising of prescription drugs: a nationally representative cross-sectional studyAbstract Fulltext PDF The world of the market placeAbstract Fulltext PDF
